BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mpagama SG, Mbelele PM, Chongolo AM, Lekule IA, Lyimo JJ, Kibiki GS, Heysell SK. Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation. BMC Public Health 2019;19:395. [PMID: 30971228 DOI: 10.1186/s12889-019-6720-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Oga-Omenka C, Tseja-Akinrin A, Sen P, Mac-Seing M, Agbaje A, Menzies D, Zarowsky C. Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review. BMJ Glob Health 2020;5:e002280. [PMID: 32616481 DOI: 10.1136/bmjgh-2019-002280] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
2 Mnyambwa NP, Philbert D, Kimaro G, Wandiga S, Kirenga B, Mmbaga BT, Muttamba W, Najjingo I, Walusimbi S, Nuwarinda R, Okelloh D, Semvua H, Ngocho J, Senkoro M, Stephen O, Castelnuovo B, Wilfred A, Mgina E, Sanga C, Aman F, Kahwa A, Mfinanga S, Ngadaya E. Gaps related to screening and diagnosis of tuberculosis in care cascade in selected health facilities in East Africa countries: A retrospective study. J Clin Tuberc Other Mycobact Dis 2021;25:100278. [PMID: 34622035 DOI: 10.1016/j.jctube.2021.100278] [Reference Citation Analysis]
3 Maokola WM, Ngowi BJ, Mahande MJ, Todd J, Robert M, Msuya SE. Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania. PLoS One 2021;16:e0254082. [PMID: 34255776 DOI: 10.1371/journal.pone.0254082] [Reference Citation Analysis]
4 Paleckyte A, Dissanayake O, Mpagama S, Lipman MC, McHugh TD. Reducing the risk of tuberculosis transmission for HCWs in high incidence settings. Antimicrob Resist Infect Control 2021;10:106. [PMID: 34281623 DOI: 10.1186/s13756-021-00975-y] [Reference Citation Analysis]
5 Loosli K, Davis A, Muwonge A, Lembo T. Addressing antimicrobial resistance by improving access and quality of care-A review of the literature from East Africa. PLoS Negl Trop Dis 2021;15:e0009529. [PMID: 34292932 DOI: 10.1371/journal.pntd.0009529] [Reference Citation Analysis]
6 Mpagama SG, Ezekiel MJ, Mbelele PM, Chongolo AM, Kibiki GS, de Guex KP, Heysell SK. Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients' perspectives from a focus group discussion. BMC Public Health 2020;20:1667. [PMID: 33160327 DOI: 10.1186/s12889-020-09774-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Lisboa M, Fronteira I, Mason PH, Martins MDRO. Using hospital auxiliary worker and 24-h TB services as potential tools to overcome in-hospital TB delays: a quasi-experimental study. Hum Resour Health 2020;18:28. [PMID: 32245488 DOI: 10.1186/s12960-020-0457-2] [Reference Citation Analysis]
8 Mpagama SG, Ramaiya K, Lillebæk T, Mmbaga BT, Sumari-de Boer M, Ntinginya NE, Alffenaar JW, Heysell SK, Bygbjerg IC, Christensen DL. Protocol for establishing an Adaptive Diseases control Expert Programme in Tanzania (ADEPT) for integrating care of communicable and non-communicable diseases using tuberculosis and diabetes as a case study. BMJ Open 2021;11:e041521. [PMID: 33910944 DOI: 10.1136/bmjopen-2020-041521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]